Aurobindo Pharma shares rise 6% on import price changes
pre-market1 source ↓written by the desknot a recommendation
- after the DGFT
- 6%
- operates at just
- 15,000-tonne capacity plant
- operates at just
- 50% utilization
- to increase
- 75%
- was trading
- ₹1,186.75
Shares of Aurobindo Pharma surged 6% after the DGFT imposed a Minimum Import Price on key antibiotic inputs, including Pen-G and Amoxicillin. This regulatory change is expected to enhance the company's pricing power and competitiveness, as its 15,000-tonne capacity plant operates at just 50% utilization, projected to increase to 75%.
The stock was trading at ₹1,186.75, up from ₹1,150.55 previously, reflecting positive market sentiment.
Not investment advice. For informational purposes only.